NFKB1 and psoriasis: Together, these findings uncover a PPARα‐FADS2‐DHA‐NF‐κB axis that links lipid metabolism to immune regulation in psoriasis, highlighting a potential therapeutic strategy for restoring cutaneous immune homeostasis.